You are here

Merck's COVID treatment expected to launch in China on Friday

Primary tabs

Wed, 2023-01-11 09:50 — mike kraft

Merck's COVID treatment expected to launch in China on Friday Merck & Co's COVID-19 antiviral treatment molnupiravir is expected to be launched in the Chinese market on Friday, Sinopharm's president Liu Yong was quoted as saying by state-backed media outlet Kankan News on Wednesday. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Groups this Group Post belongs to:

Medical - global

China Resilience Initiative

Log in or register to post comments

Page loaded in 0.480 seconds.